Facebook
Twitter
Telegram
Report an ErrorApollo Endosurgery Balance Sheet 2011-2024 | APEN
Annual Balance Sheet Apollo Endosurgery
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-22.5 M | -56.6 M | 21 M | 23.1 M | -2.81 M | 2.81 M | 20.3 M | 60.9 M | -17.3 M | -11.9 M | -24.6 M | -14.4 M |
Long Term Debt |
34 M | 33.5 M | 56.6 M | 18.6 M | 21.2 M | 33.3 M | 39.4 M | - | - | - | - | - |
Long Term Debt Current |
543 K | 587 K | 675 K | 932 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | 59 M | 19.7 M | 21.2 M | 33.3 M | 39.4 M | - | 886 K | 2.17 M | 3.61 M | 7.24 M |
Total Current Liabilities |
39.5 M | 14.5 M | 11.7 M | 52.8 M | 24.4 M | 25.8 M | 20.3 M | 1.08 M | 4.26 M | 3.53 M | 8.63 M | 10.1 M |
Total Liabilities |
77.6 M | 70.3 M | 70.7 M | 72.5 M | 45.6 M | 59.1 M | 59.7 M | 1.08 M | 5.14 M | 5.7 M | 12.2 M | 17.3 M |
Deferred Revenue |
- | - | - | - | - | - | 88 K | - | 125 K | 498 K | 5.42 M | 6.08 M |
Retained Earnings |
-337 M | -297 M | -273 M | -250 M | -223 M | -177 M | -150 M | -76 M | -66 M | -49.5 M | -42.9 M | -40.2 M |
Total Assets |
110 M | 132 M | 77.4 M | 74.6 M | 74.5 M | 109 M | 102 M | 11.6 M | 21 M | 15.7 M | 27.2 M | 17.9 M |
Cash and Cash Equivalents |
57 M | 90.7 M | 36.2 M | 29.9 M | 24 M | 30.5 M | 19.1 M | 8.89 M | 17.3 M | 11.9 M | 24.6 M | 14.4 M |
Book Value |
32.6 M | 61.2 M | 6.75 M | 2.12 M | 28.8 M | 49.9 M | 42.4 M | 10.5 M | 15.8 M | 9.97 M | 14.9 M | 629 K |
Total Shareholders Equity |
32.6 M | 61.2 M | 6.75 M | 2.12 M | 28.8 M | 49.9 M | 42.4 M | 10.5 M | 15.8 M | 9.97 M | 14.9 M | 629 K |
All numbers in USD currency
Quarterly Balance Sheet Apollo Endosurgery
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | 33.8 M | - | 33.6 M | 33.5 M | 34.6 M | 35.5 M | 37 M | 37.2 M | 37.2 M | 37.2 M | 37.2 M | - | - | - | - | 21.2 M | 21.2 M | 21.2 M | 21.2 M | 33.3 M | 33.3 M | 33.3 M | 33.3 M | 39.4 M | 39.4 M | 39.4 M | 39.4 M | 49.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | 73.7 M | - | 70 M | 70.3 M | 71.2 M | 71.7 M | 71.3 M | 70.7 M | 70.7 M | 70.7 M | 70.7 M | 72.5 M | 72.5 M | 72.5 M | 72.5 M | 45.6 M | 45.6 M | 45.6 M | 45.6 M | 59.1 M | 59.1 M | 59.1 M | 59.1 M | 59.7 M | 59.7 M | 59.7 M | 59.7 M | 94 M | 1.08 M | 1.08 M | 1.08 M | 5.14 M | 5.14 M | 5.14 M | 5.14 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 62.5 K | 125 K | 125 K | 125 K | 125 K | 498 K | 498 K | 498 K | 498 K | 5.42 M | 5.42 M | 5.42 M | 5.42 M | 6.08 M | 6.08 M | 6.08 M | 6.08 M |
Retained Earnings |
- | -328 M | - | -306 M | -297 M | -287 M | -280 M | -277 M | -273 M | -273 M | -273 M | -273 M | -250 M | -250 M | -250 M | -250 M | -223 M | -223 M | -223 M | -223 M | -177 M | -177 M | -177 M | -177 M | -150 M | -150 M | -150 M | -150 M | -109 M | -76 M | -76 M | -76 M | -66 M | -66 M | -66 M | -66 M | -49.5 M | -49.5 M | -49.5 M | -49.5 M | -42.9 M | -42.9 M | -42.9 M | -42.9 M | -40.2 M | -40.2 M | -40.2 M | -40.2 M |
Total Assets |
- | 116 M | - | 125 M | 132 M | 71.1 M | 74.4 M | 74 M | 77.4 M | 77.4 M | 77.4 M | 77.4 M | 74.6 M | 74.6 M | 74.6 M | 74.6 M | 74.5 M | 74.5 M | 74.5 M | 74.5 M | 109 M | 109 M | 109 M | 109 M | 102 M | 102 M | 102 M | 102 M | 105 M | 11.6 M | 11.6 M | 11.6 M | 21 M | 21 M | 21 M | 21 M | 15.7 M | 15.7 M | 15.7 M | 15.7 M | 27.2 M | 27.2 M | 27.2 M | 27.2 M | 17.9 M | 17.9 M | 17.9 M | 17.9 M |
Cash and Cash Equivalents |
- | 66.9 M | - | 81.7 M | 90.7 M | 28.5 M | 30.5 M | 31.7 M | 36.2 M | 36.2 M | 36.2 M | 36.2 M | 29.9 M | 29.9 M | 29.9 M | 29.9 M | 24 M | 24 M | 24 M | 24 M | 30.5 M | 30.5 M | 30.5 M | 30.5 M | 19.1 M | 19.1 M | 19.1 M | 19.1 M | 21.7 M | 8.89 M | 8.89 M | 8.89 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M | 11.9 M | 11.9 M | 11.9 M | 11.9 M | 24.6 M | 24.6 M | 24.6 M | 24.6 M | 14.4 M | 14.4 M | 14.4 M | 14.4 M |
Book Value |
- | 42.3 M | - | 55 M | 61.2 M | -92 K | 2.71 M | 2.69 M | 6.75 M | 6.75 M | 6.75 M | 6.75 M | 2.12 M | 2.12 M | 2.12 M | 2.12 M | 28.8 M | 28.8 M | 28.8 M | 28.8 M | 49.9 M | 49.9 M | 49.9 M | 49.9 M | 42.4 M | 42.4 M | 42.4 M | 42.4 M | 11.2 M | 10.5 M | 10.5 M | 10.5 M | 15.8 M | 15.8 M | 15.8 M | 15.8 M | 9.97 M | 9.97 M | 9.97 M | 9.97 M | 14.9 M | 14.9 M | 14.9 M | 14.9 M | 629 K | 629 K | 629 K | 629 K |
Total Shareholders Equity |
- | 42.3 M | - | 55 M | 61.2 M | -92 K | 2.71 M | 2.69 M | 6.75 M | 6.75 M | 6.75 M | 6.75 M | 2.12 M | 2.12 M | 2.12 M | 2.12 M | 28.8 M | 28.8 M | 28.8 M | 28.8 M | 49.9 M | 49.9 M | 49.9 M | 49.9 M | 42.4 M | 42.4 M | 42.4 M | 42.4 M | -134 M | 10.5 M | 10.5 M | 10.5 M | 15.8 M | 15.8 M | 15.8 M | 15.8 M | 9.97 M | 9.97 M | 9.97 M | 9.97 M | 14.9 M | 14.9 M | 14.9 M | 14.9 M | 629 K | 629 K | 629 K | 629 K |
All numbers in USD currency